|
|
|
Volumn 321, Issue 7258, 2000, Pages 399-
|
|
Cost effectiveness of multiple sclerosis drugs remains unknown.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERFERON;
METHOTREXATE;
ARTICLE;
COST BENEFIT ANALYSIS;
DRUG COST;
ECONOMICS;
HUMAN;
MULTIPLE SCLEROSIS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HUMANS;
INTERFERONS;
METHOTREXATE;
MULTIPLE SCLEROSIS;
|
|
EID: 0034641426
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
